SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001813314-21-000001
Filing Date
2021-08-17
Accepted
2021-08-17 19:24:04
Documents
1
Period of Report
2021-08-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 7367
  Complete submission text file 0001813314-21-000001.txt   9548
Mailing Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016
Business Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016 (646) 600-6438
IN8BIO, INC. (Issuer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 817-381-5370
BP Directors, LP (Reporting) CIK: 0001813311 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39692 | Film No.: 211184574

Mailing Address 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 817-381-5370
Bios Equity Partners, LP (Reporting) CIK: 0001813314 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39692 | Film No.: 211184575